Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Glioblastoma Multiforme”

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04216329
What this trial is testing

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GliosarcomaNewly DiagnosedGlioblastoma
National Cancer Institute (NCI) 11
Large-scale testing (Phase 3)Looking for participantsNCT07452458
What this trial is testing

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma
NRG Oncology 398
Testing effectiveness (Phase 2)WithdrawnNCT02432417
What this trial is testing

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

Who this might be right for
GlioblastomaAstrocytoma, Grade IV
Maastricht Radiation Oncology
Testing effectiveness (Phase 2)Active Not RecruitingNCT04752813
What this trial is testing

BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Who this might be right for
GlioblastomaGlioblastoma Multiforme
BPGbio 50
Testing effectiveness (Phase 2)UnknownNCT02137759
What this trial is testing

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Who this might be right for
Glioblastoma Multiforme of Brain
Emory University 29
Testing effectiveness (Phase 2)Study completedNCT00458601
What this trial is testing

Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Celldex Therapeutics 82
Testing effectiveness (Phase 2)Study completedNCT00028795
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Oncology Group 170
Early research (Phase 1)Study completedNCT03224104
What this trial is testing

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

Who this might be right for
Astrocytoma, Grade IIIGlioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 71
Not applicableUnknownNCT02904525
What this trial is testing

Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model

Who this might be right for
Glioblastoma
Andreas Hottinger 20
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Not applicableWithdrawnNCT00645385
What this trial is testing

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma
Weill Medical College of Cornell University
Not applicableEnded earlyNCT02039778
What this trial is testing

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

Who this might be right for
GlioblastomaMalignant GliomaBrain Tumors+1 more
Beth Israel Medical Center 4
Testing effectiveness (Phase 2)Ended earlyNCT04421378
What this trial is testing

Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Karyopharm Therapeutics Inc 74
Large-scale testing (Phase 3)Looking for participantsNCT07021339
What this trial is testing

Anterior Temporal Lobectomy in Temporal Glioblastoma

Who this might be right for
Newly-diagnosed GlioblastomaTemporal Lobe
University Hospital, Bonn 178
Large-scale testing (Phase 3)Study completedNCT00807027
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

Who this might be right for
Glioblastoma
GC Cell Corporation 180
Early research (Phase 1)Study completedNCT04474353
What this trial is testing

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed Glioblastoma
Stanford University 12
Testing effectiveness (Phase 2)WithdrawnNCT00005083
What this trial is testing

Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT02254954
What this trial is testing

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Actelion 30
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Very early researchLooking for participantsNCT06072586
What this trial is testing

BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Who this might be right for
High Grade GliomaGlioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 82
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation